• Login
    View Item 
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Author
    Edmonds, Sterling
    MacGregor, Andrea
    Doll, Agnieszka
    Vural, Ipek Eren
    Graham, Janice
    Fierlbeck, Katherine
    Lexchin, Joel
    Doshi, Peter
    Herder, Matthew
    Date
    2020-11-19
    Journal
    Journal of Law and the Biosciences
    Publisher
    Oxford University Press
    Type
    Article
    
    Metadata
    Show full item record
    See at
    https://doi.org/10.1093/jlb/lsaa083
    Keyword
    COVID-19
    pandemic
    pharmaceutical regulation
    transparency
    vaccines and drugs
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/14655
    ae974a485f413a2113503eed53cd6c53
    10.1093/jlb/lsaa083
    Scopus Count
    Collections
    UMB Coronavirus Publications
    Dr. Peter Doshi
    UMB Open Access Articles

    entitlement

    Related articles

    • A compromise too far: a review of Canadian cases of direct-to-consumer advertising regulation.
    • Authors: Lexchin J, Mintzes B
    • Issue date: 2014
    • Trust and transparency in times of crisis: Results from an online survey during the first wave (April 2020) of the COVID-19 epidemic in the UK.
    • Authors: Enria L, Waterlow N, Rogers NT, Brindle H, Lal S, Eggo RM, Lees S, Roberts CH
    • Issue date: 2021
    • Regulators, Pivotal Clinical Trials, and Drug Regulation in the Age of COVID-19.
    • Authors: Lexchin J, Graham J, Herder M, Jefferson T, Lemmens T
    • Issue date: 2021 Jan
    • Toward a jurisprudence of drug regulation.
    • Authors: Herder M
    • Issue date: 2014 Summer
    • A real-time policy dashboard can aid global transparency in the response to coronavirus disease 2019.
    • Authors: Head MG
    • Issue date: 2020 Sep 1
    DSpace software (copyright © 2002 - 2022)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.